Medicare (CMS) August 5th 2018 Local Coverage Determination (LCD) Updates

Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »

August 5th Medicare (CMS) 2018 LCD Updates:

• L35162              Ambulance Services (Ground Ambulance)
• A53049             Approved Drugs and Biologicals; Includes Cancer Chemotherapeutic Agents
• A52422             Autologous Cellular Immunotherapy Treatment of Metastatic Prostate Cancer
• A55353 (retired) Billing and Coding for Rezum® Procedure
• A56083             Billing and Coding for the Rezum® System for Benign Prostatic
• A55035             Billing Requirements for Application of Skin Substitutes (Part B Services Only)
• A52530             Capsaicin 8% patch (Qutenza®)
• L33423              Cardiac Computed Tomography & Angiography (CCTA)
• L34093              Chemotherapy and Biologicals
• L34093              Chemotherapy and Biologicals
• L37387              Chiropractic Services
• A52424             Denosumab (Prolia ™, Xgeva ™)
• L33812 (retired) Destruction by neurolytic agent; interdigital nerve of the foot—Morton’s Neuroma
• A56085             Destruction by neurolytic agent; interdigital nerve of the foot—Morton’s neuroma retired Part B LCD
• A52425             Drugs and Biologicals, Coverage of, for Label and Off-Label Uses – Supplemental Instructions Article
• A52531             Fluocinolone acetonide intravitreal implant
• L36926 (retired) Genomic Sequence Analysis Panels in the Treatment of Acute Myelogenous Leukemia (AML)
• L37606              Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases
• L37078 (retired) Genomic Sequence Analysis Panels in the Treatment of Myelodysplastic Syndromes (MDS)
• L36761              GlycoMark Testing for Glycemic Control
• A53055             Home-Based Fall Evaluations and Interventions
• L37779              Intraoperative Radiation Therapy
• A52427             Iron Sucrose, Iron Dextran and Ferumoxytol, (Intravenous Iron Therapy)
• L34012 (retired) Leucovorin (Wellcovorin®)
• A56087             Leucovorin (Wellcovorin®) retired Part A and Part B LCD
• L36007              Lower Extremity Major Joint Replacement (Hip and Knee)
• L34822              Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
• L37761              Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for Essential Tremor
• L36082              MolDX: BRCA1 and BRCA2 Genetic Testing
• L36161              MolDX: BRCA1 and BRCA2 Genetic Testing
• L36163              MolDX: BRCA1 and BRCA2 Genetic Testing
• A54878             MolDX: CDH1 Genetic Testing Coding and Billing Guidelines
• L35071              MolDX: Circulating Tumor Cell Marker Assays
• L35024              MolDX: Genetic Testing for Lynch Syndrome
• L36002              MolDX: Prolaris™ Prostate Cancer Genomic Assay
• L37260              MolDX: Prometheus IBD sgi Diagnostic Policy
• A54862             Nivolumab – Related to LCD L33394
• L34555              Non-Covered Category III CPT Codes
• A52532             Off-Label Cancer Chemotherapy Use
• A52428             Pamidronate Disodium for Injection (e.g., Aredia®)
• L34063              RAST Type Tests
• L34200              Removal of Benign Skin Lesions
• A56089             Response to Comments: GlycoMark Testing for Glycemic Control
• A56088             Response to Comments: Intraoperative Radiation Therapy
• A56084             Response to Comments: Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for Essential Tremor
• A56090             Response to Comments: MolDX: Circulating Tumor Cell Marker Assays
• L34246              Routine Foot Care and Debridement of Nails
• A52372             Routine Foot Care and Debridement of Nails – Supplemental Instructions Article
• L34061              Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
• A52429             Sodium Ferric Gluconate, (Intravenous Iron Therapy)
• L34046              Speech-Language Pathology
• A52533             Thyrotropin Alfa (Thyrogen®)
• L33473              Vertebroplasty/Kyphoplasty

Centers for Medicare & Medicaid Services (CMS) Local Coverage Determination (LCD) Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.